Category / Tellus News Items

    Loading posts...
  • Therapeutic Innovations Stand Out to Investors at Triangle Venture Day

    Mon, 09/29/2025 Kyle Marshall, NCBiotech Original article: https://www.ncbiotech.org/news/therapeutic-innovations-stand-out-investors-triangle-venture-day If you want to know how therapeutic innovation in the Triangle stacks up against other life sciences hubs, just ask an investor who knows the national and global landscape. Nima Ronaghi, principal at Breakout Ventures, a San Francisco fund that invests in early-stage, science-backed companies, said the…

  • C-Path Launches Global Collaborative to Advance Drug Development for Neonatal Brain Injury

    TUCSON, Ariz., June 20, 2025 — The Critical Path Institute® (C-Path), through its International Neonatal Consortium (INC), is proud to announce the official launch of the Neonatal Brain Injury Collaborative (NBIC) — a global, pre-competitive initiative aimed at accelerating the development of safe and effective therapies for conditions such as hypoxic-ischemic encephalopathy (HIE) and neonatal white matter injury.

  • Tellus Therapeutics – Traction in 2020

    March 11th, 2020

    Tellus Therapeutics is on target for a productive 2020 and is gaining traction towards its mission of developing treatments for unmet needs in newborns.

  • First Ever Golden Ticket Awarded to Dr. Eric Benner

    December 10, 2019

    Duke Clinical & Translational Science Institute and BioLabs North Carolina have awarded the first ever Duke Golden Ticket to Dr. Eric Benner, Assistant Professor of Pediatrics in the Duke School of Medicine, and co-founder of Tellus Therapeutics.

  • MassChallenge Startup Competition Winner Uses Breast Milk to Fight Cerebral Palsy

    Andy Rosen, Boston Globe Staff – October 24, 2019

    A North Carolina startup that uses molecules from breast milk to help prevent cerebral palsy took home a $100,000 grant Thursday night, the top prize in the annual awards program carried out by MassChallenge, a nonprofit accelerator program for promising businesses.

  • Tellus Therapeutics Wins Early Stage Company Shootout

    SEBIO – December 4, 2018

    An A-List Group Of Investors And Companies Attended The 20th Anniversary Southeast BIO Investor & Partnering Forum (SEBIO) On November 13-14th At The Loews Hotel In Atlanta.